These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19787556

  • 1. Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives.
    Levi M, Hobbs FD, Jacobson AK, Pisters R, Prisco D, Bernardo A, Haas M, Heidrich J, Rosenberg M, Nielsen JD, Wuillemin WA.
    Semin Thromb Hemost; 2009 Sep; 35(6):527-42. PubMed ID: 19787556
    [Abstract] [Full Text] [Related]

  • 2. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [Abstract] [Full Text] [Related]

  • 3. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [Abstract] [Full Text] [Related]

  • 4. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms.
    Pisters R, de Vos CB, Nieuwlaat R, Crijns HJ.
    Semin Thromb Hemost; 2009 Sep; 35(6):554-9. PubMed ID: 19787559
    [Abstract] [Full Text] [Related]

  • 5. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ, Euro Heart Survey Investigators.
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [Abstract] [Full Text] [Related]

  • 6. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA.
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [Abstract] [Full Text] [Related]

  • 7. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL, Corbett TL.
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [Abstract] [Full Text] [Related]

  • 8. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG, Albers GW.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):929-35. PubMed ID: 15028346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM, Boom K, Jackson SL, Vial JH.
    Intern Med J; 2002 Mar 17; 32(1-2):15-23. PubMed ID: 11783668
    [Abstract] [Full Text] [Related]

  • 13. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.
    Arch Intern Med; 2007 Feb 12; 167(3):246-52. PubMed ID: 17296879
    [Abstract] [Full Text] [Related]

  • 14. Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
    Hylek EM.
    Semin Thromb Hemost; 2009 Sep 12; 35(6):548-53. PubMed ID: 19787558
    [Abstract] [Full Text] [Related]

  • 15. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.
    Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC, Albers GW.
    Clin Geriatr Med; 1999 Nov 11; 15(4):645-62. PubMed ID: 10499928
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
    Go AS.
    Am J Manag Care; 2004 Apr 11; 10(3 Suppl):S58-65. PubMed ID: 15152747
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 11; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I, Bajpai A, Camm AJ.
    Ann Med; 2007 Jun 11; 39(5):371-91. PubMed ID: 17701479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.